Test Your Knowledge Issue 442
A 52-year-old man who has had type 2 diabetes for 5 years is admitted to the hospital because of a flare of chronic obstructive pulmonary disease. His diabetes was previously well controlled with metformin 1000 mg twice...
Lifecycle Management Techniques
Every week I see a list of drugs that are going to be available generically but some of them never seem to appear. Elizabeth Brule, PharmD Candidate, University of Florida College of Pharmacy, has done some research as to why that occurs and if you...
Too Few Americans Aware of 'Pre-Diabetes'
It's when blood sugar levels are rising, but disease can still be prevented, CDC says. With over 25% of Americans with pre-diabetes, only 4% are aware they have pre-diabetes.
Fish Intake Lowers Albuminuria in People With Diabetes
Fish intake lowered the risk for macroalbuminuria and kidney disease in patients with diabetes, according to the results of a cross-sectional study.
Once A Week Byetta In Jeopardy
Struggling for years to launch a new drug, Eli Lilly and Co. suffered yet another setback when its partners said Tuesday that federal regulators rejected data for a long-acting version of the diabetes drug Byetta.
Vitamins E and C Supplements Not Effective For Prevention of Cardiovascular Disease
Neither vitamin E nor vitamin C supplements reduced the risk of major cardiovascular events in a large, long-term study of male physicians, according to a new study.
Recall of Mislabeled ReliOn Insulin Syringes
Mislabeled insulin syringes can cause patients to get 2.5 times more insulin then expected.
Diabetes, Hypertension Hasten Death in Alzheimer's Patients
They're more than twice as likely to die sooner, study finds. Having diabetes or high blood pressure may hasten the death of people with Alzheimer's disease, new research suggests.
Completely Novel Action Of Insulin Unveiled
A Ph.D. student at Sydney's Garvan Institute of Medical Research has uncovered an important piece in the puzzle of how insulin works, a problem that has plagued researchers for more than 50 years. The research brings scientists one step closer to...
New SIRT1 Activator Improves Glucose Tolerence and Insulin Sensitivity
A study demonstrates that a synthetic new chemical entity protects against diet-induced obesity, improves glucose tolerance and insulin sensitivity and enhances exercise endurance by enhancing fat utilization in certain target tissues.
Acarbose Improves Insulin Levels in Overweight Women With PCOS
Acarbose, an alpha-glucosidase inhibitor, improves hyperinsulinemia in overweight women with polycystic ovarian syndrome (PCOS), according to a report in the October issue of Fertility and Sterility.
Obama Wins: What It Means for Healthcare
Tuesday's election of Democrat Barack Obama ushers in a new administration that is all but certain to include some level of health care reform. Less clear is how extensive that reform will be and when it will come. Hopefully prevention will be a key...
Energy-Restricted, High-Monounsaturated Fat Diet Helpful in Type 2 Diabetes
An energy-restricted, high-monounsaturated fat (MUFA) diet is as effective as a high-carbohydrate (CHO), low-fat diet in persons with type 2 diabetes, according to the results of a study.
Ten-Year Follow-up of UKPDS Shows No Legacy Effect of In-trial Blood Pressure Control
The 10-year follow-up results of the United Kingdom Prospective Diabetes Study (UKPDS) show that the benefits seen in patients originally assigned to a strategy of tight blood pressure control were not sustained once the differences in blood pressure...
Age Thresholds for Routine Aspirin Use Defined
If aspirin is to be used routinely for primary prevention of cardiovascular disease, it should begin at age 48 in men and 57 in women, according to a report in the November issue of Heart.
Fear of Shark Bites Greater Than Fear of Diabetes Complications
Americans more fearful of shark bites than this common, potentially lethal disease, survey shows, even though 233,429 people die from diabetes related causes and 70 people worldwide die from shark attacks.
Metformin Reduces CardioVascular Mortality Risk by 26%
The widely prescribed metformin was alone among oral antidiabetic agents to show a significant effect on cardiovascular (CV) risk in a meta-analysis of 40 select controlled trials. It reduced CV mortality by 26% relative to any other antidiabetic ...
